These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 25162953)
1. Characterization of patients receiving palliative chemo- and radiotherapy during end of life at a regional cancer center in Norway. Anshushaug M; Gynnild MA; Kaasa S; Kvikstad A; Grønberg BH Acta Oncol; 2015 Mar; 54(3):395-402. PubMed ID: 25162953 [TBL] [Abstract][Full Text] [Related]
2. Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG-ps) in patients receiving palliative chemotherapy for gastroesophageal cancer. Crumley AB; Stuart RC; McKernan M; McDonald AC; McMillan DC J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e325-9. PubMed ID: 17645468 [TBL] [Abstract][Full Text] [Related]
3. Use of Palliative Chemo- and Radiotherapy at the End of Life in Patients With Cancer: A Retrospective Cohort Study. Zhang Z; Gu XL; Chen ML; Liu MH; Zhao WW; Cheng WW Am J Hosp Palliat Care; 2017 Nov; 34(9):801-805. PubMed ID: 27281134 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of nutritional and inflammatory status of advanced colorectal cancer patients and its correlation with survival. Read JA; Choy ST; Beale PJ; Clarke SJ Nutr Cancer; 2006; 55(1):78-85. PubMed ID: 16965244 [TBL] [Abstract][Full Text] [Related]
5. Glasgow prognostic score predicts prognosis for cancer patients in palliative settings: a subanalysis of the Japan-prognostic assessment tools validation (J-ProVal) study. Miura T; Matsumoto Y; Hama T; Amano K; Tei Y; Kikuchi A; Suga A; Hisanaga T; Ishihara T; Abe M; Kaneishi K; Kawagoe S; Kuriyama T; Maeda T; Mori I; Nakajima N; Nishi T; Sakurai H; Morita T; Kinoshita H Support Care Cancer; 2015 Nov; 23(11):3149-56. PubMed ID: 25777319 [TBL] [Abstract][Full Text] [Related]
6. A prospective survey of radiotherapy in Sweden. Acta Oncol; 1996; 35 Suppl 6():47-56. PubMed ID: 9154085 [TBL] [Abstract][Full Text] [Related]
7. Survival after palliative radiotherapy in geriatric cancer patients. Nieder C; Angelo K; Haukland E; Pawinski A Anticancer Res; 2014 Nov; 34(11):6641-5. PubMed ID: 25368269 [TBL] [Abstract][Full Text] [Related]
8. The application of the Palliative Prognostic Index, charlson comorbidity index, and Glasgow Prognostic Score in predicting the life expectancy of patients with hematologic malignancies under palliative care. Chou WC; Kao CY; Wang PN; Chang H; Wang HM; Chang PH; Yeh KY; Hung YS BMC Palliat Care; 2015 Apr; 14():18. PubMed ID: 25924723 [TBL] [Abstract][Full Text] [Related]
9. Palliative Chemotherapy Near the End of Life in Oncology Patients. Zhang Z; Chen ML; Gu XL; Liu MH; Zhao WW; Cheng WW Am J Hosp Palliat Care; 2018 Sep; 35(9):1215-1220. PubMed ID: 29529885 [TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in patients who received end-of-life chemotherapy for advanced cancer. Hiramoto S; Tamaki T; Nagashima K; Hori T; Kikuchi A; Yoshioka A; Inoue A Int J Clin Oncol; 2019 Apr; 24(4):454-459. PubMed ID: 30377853 [TBL] [Abstract][Full Text] [Related]
11. Aggressiveness of end-of-life care for patients with colorectal cancer in Alberta, Canada: 2006-2009. Hu W; Yasui Y; White J; Winget M J Pain Symptom Manage; 2014 Feb; 47(2):231-44. PubMed ID: 23870414 [TBL] [Abstract][Full Text] [Related]
12. C-Reactive Protein/Albumin Ratio Is an Independent Prognostic Predictor of Survival in Advanced Cancer Patients Receiving Palliative Care. Zhang J; Zhang C; Li Q; Zhang J; Gu X; Zhao W; Chen M; Liu M; Zhang Z; Liao X; Cheng W J Palliat Med; 2019 Dec; 22(12):1536-1545. PubMed ID: 31188054 [No Abstract] [Full Text] [Related]
13. Administration of chemotherapy with palliative intent in the last 30 days of life: the balance between palliation and chemotherapy. Zdenkowski N; Cavenagh J; Ku YC; Bisquera A; Bonaventura A Intern Med J; 2013 Nov; 43(11):1191-8. PubMed ID: 23870085 [TBL] [Abstract][Full Text] [Related]
14. Aggressiveness of cancer-care near the end-of-life in Korea. Keam B; Oh DY; Lee SH; Kim DW; Kim MR; Im SA; Kim TY; Bang YJ; Heo DS Jpn J Clin Oncol; 2008 May; 38(5):381-6. PubMed ID: 18411260 [TBL] [Abstract][Full Text] [Related]
15. Palliative radiotherapy tailored to life expectancy in end-stage cancer patients: reality or myth? Gripp S; Mjartan S; Boelke E; Willers R Cancer; 2010 Jul; 116(13):3251-6. PubMed ID: 20564632 [TBL] [Abstract][Full Text] [Related]
16. Pattern of cancer deaths in a saudi tertiary care hospital. Al-Zahrani AS; El-Kashif AT; Haggag RM; Alsirafy SA Am J Hosp Palliat Care; 2013 Feb; 30(1):21-4. PubMed ID: 22378940 [TBL] [Abstract][Full Text] [Related]
17. Belgian general practitioners' perspectives on the use of palliative sedation in end-of-life home care: a qualitative study. Sercu M; Pype P; Christiaens T; Derese A; Deveugele M J Pain Symptom Manage; 2014 Jun; 47(6):1054-63. PubMed ID: 24095283 [TBL] [Abstract][Full Text] [Related]
18. Anticancer therapy at end-of-life: A retrospective cohort study. Singh J; Stensvold A; Turzer M; Grov EK Acta Oncol; 2024 May; 63():313-321. PubMed ID: 38716486 [TBL] [Abstract][Full Text] [Related]
19. Effect of integrated palliative care on the quality of end-of-life care: retrospective analysis of 521 cancer patients. Colombet I; Montheil V; Durand JP; Gillaizeau F; Niarra R; Jaeger C; Alexandre J; Goldwasser F; Vinant P BMJ Support Palliat Care; 2012 Sep; 2(3):239-47. PubMed ID: 24654196 [TBL] [Abstract][Full Text] [Related]
20. Factors that affect the duration of the interval between the completion of palliative chemotherapy and death. Hashimoto K; Yonemori K; Katsumata N; Hotchi M; Kouno T; Shimizu C; Tamura K; Ando M; Takeuchi M; Fujiwara Y Oncologist; 2009 Jul; 14(7):752-9. PubMed ID: 19596665 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]